Do Patents Drive or Hinder Innovation?
Here’s a brief note in response to some of the discussions I’ve seen regarding the merit of patents. Many of […]
General Biotechnology
Uncategorized
New patent expiration for Mallinckrodt Hosp drug INOMAX
Annual Drug Patent Expirations for INOMAX Inomax is a drug marketed by Mallinckrodt Hosp and is included in one NDA. It is available from one supplier. There are seventeen patents…
The post New patent expiration for Mallinckrodt Hosp drug INOMAX …
New patent expiration for Mallinckrodt Hosp drug INOMAX Read Post »
Uncategorized
New patent expiration for Merck Sharp drug INVANZ
Annual Drug Patent Expirations for INVANZ Invanz is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier. There is one…
The post New patent expiration for Merck Sharp drug INVANZ appeared first on Dru…
New patent expiration for Merck Sharp drug INVANZ Read Post »
Insights
Rising Pharmaceutical Costs a Major Challenge for Managed Healthcare
The steep rise in pharmaceutical prices year over year is old news at this point. Even a number of generic drugs are going up in price, causing difficulties for insurers…
The post Rising Pharmaceutical Costs a Major Challenge for Managed Healthca…
Rising Pharmaceutical Costs a Major Challenge for Managed Healthcare Read Post »
Uncategorized
New patent expiration for Novartis drug STARLIX
Annual Drug Patent Expirations for STARLIX Starlix is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are four patents protecting…
The post New patent expiration for Novartis drug STARLIX appeared …
General Biotechnology, Insights
Should Price or Product Be the Determinant in Pharmaceutical Competition?
Pharmaceutical competition incorporates different tactics in different markets because countries have divergent approaches to regulating healthcare costs. Both price and product have roles in defining the competitive landscape in pharmaceuticals,……
Should Price or Product Be the Determinant in Pharmaceutical Competition? Read Post »
Uncategorized
Drug Patent Expirations for the Week of November 12, 2017
INVEGA SUSTENNA (paliperidone palmitate) Janssen pharms Patent: 6,077,843 Expiration: Nov 12, 2017 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug …
Drug Patent Expirations for the Week of November 12, 2017 Read Post »
Uncategorized
New patent expiration for Sankyo drug PRELAY
Annual Drug Patent Expirations for PRELAY Prelay is a drug marketed by Sankyo and is included in one NDA. There are two patents protecting this drug. This drug has forty-five…
The post New patent expiration for Sankyo drug PRELAY appeared first o…
Uncategorized
New patent expiration for Janssen Pharms drug INVEGA TRINZA
Annual Drug Patent Expirations for INVEGA+TRINZA Invega Trinza is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There is one…
The post New patent expiration for Janssen Pharms drug INVEGA TRINZA …
New patent expiration for Janssen Pharms drug INVEGA TRINZA Read Post »
Uncategorized
Drug Patent Expirations for the Week of November 12, 2017
INVEGA SUSTENNA (paliperidone palmitate) Janssen pharms Patent: 6,077,843 Expiration: Nov 12, 2017 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug …
Drug Patent Expirations for the Week of November 12, 2017 Read Post »
